cardiovascular-disease

Documents about cardiovascular-disease

• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors#201724ClinicalTrials.gov
• The principles of Population-Level Approaches to Dementia Risk Reduction (PLADRR)#141267PLOS
• Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship#424203ClinicalTrials.gov
• Sex-specific assumptions underlie cardiovascular digital twin technologies: A narrative review#626373PLOS
• Risk prediction for cardiovascular related diseases using PRS and EHR in the Framingham Heart Study#28665PLOS
• SUSTAIN: Behavior Change and Nutrition Security for CKMS#842048ClinicalTrials.gov
• Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study#175003ClinicalTrials.gov
• Healthy Living With Online suPport & Education for Cardiovascular Disease in the Primary Care Setting#290926ClinicalTrials.gov
• Micro-nanoplastics and cardiovascular diseases: evidence and perspectives#374732IRIS
• Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease#471595ClinicalTrials.gov
• Proactive Population Health Management of Cardiovascular Disease in Primary Care Using the PROSPERA-program.#474864ClinicalTrials.gov
• Effect of a Spice Blend on Cardiovascular Risk Factors and Diet Satisfaction#831018ClinicalTrials.gov
• Nutritional Screening in Cardiovascular Disease#844277ClinicalTrials.gov
• Cardiovascular-Renal Adverse Prognosis Assessment System for Coronary Heart Disease With Chronic Kidney Disease Based on Metabolomics#845150ClinicalTrials.gov
• Endothelial Function and Vein Graft Remodeling#850266ClinicalTrials.gov
• Pathological Changes in the Cardiovascular System in Valvular Heart Disease#851537ClinicalTrials.gov
• Machine learning–driven integration of 24-hour ambulatory blood pressure and its variability#376026PLOS
• CommunityRx-Cardiovascular Disease Patient Surveys, 2024-2025#425932UNC Dataverse Dataverse OAI Archive
• PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study#848826ClinicalTrials.gov
• Białystok PLUS - Polish Longitudinal University Study#279671ClinicalTrials.gov
• Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia#366698ClinicalTrials.gov
• Rationale and design of the PREGnancy, HEART Health and Cardiovascular Disease (PREG-HEART) Cohort Study#133209bioRxiv / medRxiv
• Prediction of Quality of Life in Cardiovascular Disease#184708ClinicalTrials.gov
• Cardiovascular Disease Risk Factors in Chinese American Immigrants#245386ClinicalTrials.gov
• Decline in Cardiovascular Mortality: Framingham 1950-1984#383639ClinicalTrials.gov
• Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women#398275ClinicalTrials.gov
• Patient Perspectives on Potential Implementation of Coordinated Family Care Visits for Inherited Cardiovascular Disease#657304bioRxiv / medRxiv
• Growth Hormone's Effect on Endothelial Progenitor Cells#849150ClinicalTrials.gov
• Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients#826491ClinicalTrials.gov
• Human papillomavirus infection and risk of cardiovascular disease: A population-based matched cohort study with sibling analysis#631443PLOS
• Integrated Assessment of Oxidative Stress, Cardiac Injury, and Inflammatory Biomarkers in Patients with Cardiovascular Disease#427404HAL (France)
• Enhanced cardiovascular disease risk prediction using explainable machine learning and data balancing#438686Figshare
• Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD)#828691ClinicalTrials.gov
• Behavioral Factors in Coronary Heart Disease#802130ClinicalTrials.gov
• LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation#455616PLOS
• Effects of Lipemia and Metformin on Endothelial Function#148713ClinicalTrials.gov
• New Molecular Mechanisms for Cardiovascular Disease:<BR>Preface#194667J-STAGE (Japan)
• Heart Outcomes Prevention Evaluation-3#208379ClinicalTrials.gov
• Olmesartan Medoxomil in Atherosclerosis#424280ClinicalTrials.gov
• Novel Mediators of Diabetes-Associated Cardiovascular Disease#643769Harvard DASH
• Características clínico-epidemiológicas de pacientes con úlceras en extremidades inferiores#283256DIALNET OAI Articles
• Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)#849175ClinicalTrials.gov
• Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)#121296ClinicalTrials.gov
• Mediterranean Diet and cardiovascular diseases: A 2024 update#173047HAL (France)
• Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes#290861ClinicalTrials.gov
• Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension#417455ClinicalTrials.gov
• Depressive Symptoms and Prevalent Cardiovascular Disease: A Cross-Sectional Analysis in Port-au-Prince, Haiti#480189bioRxiv / medRxiv
• Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism#836724ClinicalTrials.gov
• OPTIMISation of Cardio-renal-metabolic-pulmonary Disease Guideline Adherence in High Risk Community Dwelling Individuals#463698ClinicalTrials.gov
• Chronic Kidney Disease Prevention of An-Lo District, Keelung#825304ClinicalTrials.gov